Literature DB >> 15348993

Superior oblique myokymia caused by vascular compression.

Masato Hashimoto1, Kenji Ohtsuka, Yasuo Suzuki, Yoshihiro Minamida, Kiyohiro Houkin.   

Abstract

A 49-year-old man had left superior oblique myokymia for eight years. Magnetic resonance images with enhanced spoiled gradient recalled acquisition in the steady state (SPGR) and flow imaging using steady acquisition (FIESTA) disclosed a branch of the superior cerebellar artery lying on the root exit zone of the left trochlear nerve. Posterior fossa craniotomy confirmed the imaging findings. A Teflon pad was placed between the compressing artery and the trochlear nerve. The patient's superior oblique myokymia has completely resolved with a one-year follow-up. Only one such case has been previously reported. This is the first report to display the imaging findings.

Entities:  

Mesh:

Year:  2004        PMID: 15348993     DOI: 10.1097/00041327-200409000-00012

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  4 in total

1.  Vascular compressive optic neuropathy caused by hypertensive intracranial ophthalmic artery.

Authors:  Fumihito Hikage; Masato Hashimoto; Hiroshi Ohguro
Journal:  Jpn J Ophthalmol       Date:  2010-11-05       Impact factor: 2.447

2.  Variable relations of the trochlear nerve with the pontomesencephalic segment of the superior cerebellar artery.

Authors:  Mugurel Constantin Rusu; Alexandra Diana Vrapciu; Jenel Marian Pătraşcu
Journal:  Surg Radiol Anat       Date:  2014-09-19       Impact factor: 1.246

3.  A 67-year-old woman with shaking of the world.

Authors:  Stephen J Turner; Paul Riordan-Eva; Steve Connor; Michael Samuel
Journal:  Digit J Ophthalmol       Date:  2008-06-15

Review 4.  Therapy of Vestibular Paroxysmia, Superior Oblique Myokymia, and Ocular Neuromyotonia.

Authors:  Michael Strupp; Marianne Dieterich; Thomas Brandt; Katharina Feil
Journal:  Curr Treat Options Neurol       Date:  2016-07       Impact factor: 3.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.